SCHEMBL1551982

SCHEMBL1551982

O=C(O)C1=C(O)C(O)CCC1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.39
HSD17B10 Q99714 1/20 0.39
OAT P04181 1/20 0.34
ACMSD Q8TDX5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20450103 0.77 OAT (0.33) OAT
SCHEMBL6810992 0.70 DHODH (0.43)
SCHEMBL18864186 0.69
SCHEMBL5474955 0.68 KDM4E (0.39) GAAHSD17B10OAT
SCHEMBL12491709 0.67 DHODH (0.41)
SCHEMBL217840 0.67 DHODH (0.41)
SCHEMBL252263 0.67 DHODH (0.45)
SCHEMBL17024326 0.67 DHODH (0.41)
SCHEMBL17024327 0.67 DHODH (0.41)
SCHEMBL12491707 0.67 DHODH (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116875641-A Feeding method for improving fermentation yield of rapamycin 丽珠集团福州福兴医药有限公司 2023-10-13 CN disclosed
US-9605001-B2 Production of polyketides and other natural products BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2017-03-28 US disclosed
US-20150266896-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS BIOTICA TECH LTD (GB) 2015-09-24 US disclosed
EP-1521828-B1 PRODUCTION OF POLYKETIDES BUCK INST FOR RES ON AGING (US) 2015-07-01 EP disclosed
US-9040259-B2 Production of polyketides and other natural products BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2015-05-26 US disclosed
US-20110165633-A1 Production of Polyketides and Other Natural Products BUCK INSTITUTE FOR RESEARCH ON AGING 2011-07-07 US disclosed
EP-2313419-A1 NOVEL COMPOUNDS AND METHODS FOR THEIR PRODUCTION Biotica Technology Limited (GB) 2011-04-27 EP disclosed
WO-2010106366-A1 FK506 AND FK520 ANALOGUES AND THEIR PHARMACEUTICAL USES BIOTICA TECHNOLOGY LIMITED (GB) 2010-09-23 WO disclosed
US-7714118-B2 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration KOSAN BIOSCIENCES INCORPORATED (US) 2010-05-11 US disclosed
WO-2010004304-A1 NOVEL COMPOUNDS AND METHODS FOR THEIR PRODUCTION BIOTICA TECHNOLOGY LIMITED (GB) 2010-01-14 WO disclosed
US-6759536-B2 GENETIC ENGINEERING; POLYKETIDES KOSAN BIOSCIENCES, INC. 2004-07-06 US disclosed
WO-2004007709-A2 PRODUCTION OF POLYKETIDES BIOTICA TECHNOLOGY LIMITED (GB) 2004-01-22 WO disclosed
US-6670168-B1 Cell comprises a modified rapamycin polyketide synthase (PKS) gene cluster with an acyltransferase (AT) domain in extender module 10 having malonyl CoA specificity. KOSAN BIOSCIENCE, INC. 2003-12-30 US disclosed
US-6660862-B2 Genetic engineering KOSAN BIOSCIENCES, INC. 2003-12-09 US disclosed
US-20030175901-A1 Genetic engineering; polyketides REEVES CHRISTOPHER (US) 2003-09-18 US disclosed
US-6503737-B1 Host cells comprising recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide. Recombinant DNA constructs comprising one or more FK-520 polyketide synthase KOSAN BIOSCIENCES, INC. 2003-01-07 US disclosed
US-20020010328-A1 Genetic engineering REEVES CHRISTOPHER (US) 2002-01-24 US disclosed
EP-1117801-A2 POLYKETIDE SYNTHASE ENZYMES AND RECOMBINANT DNA CONSTRUCTS THEREFOR Kosan Biosciences, Inc. (US) 2001-07-25 EP disclosed
WO-2000020601-A9 POLYKETIDE SYNTHASE ENZYMES AND RECOMBINANT DNA CONSTRUCTS THEREFOR KOSAN BIOSCIENCES INC (US) 2000-08-31 WO disclosed
WO-2000020601-A2 POLYKETIDE SYNTHASE ENZYMES AND RECOMBINANT DNA CONSTRUCTS THEREFOR KOSAN BIOSCIENCES, INC. (US) 2000-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266896-A1 PRODUCTION OF POLYKETIDES AND OTHER NATURAL PRODUCTS FKBP14, FKBP4, FKBP2 GAA 668/4885HSD17B10 547/4885OAT 3825/4885
US-20020010328-A1 Genetic engineering FDPS, DTYMK, COASY GAA 84/4885HSD17B10 206/4885OAT 1707/4885
US-20030175901-A1 Genetic engineering; polyketides FDPS, PFAS, COASY GAA 107/4885HSD17B10 167/4885OAT 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.